Markets.com Logo

MNMD

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    9.2858$
  • Previous Close
    9.8449$
  • 52 Week Change
    5.79$
  • Day Range
    -0.56$
  • 52 Week High/Low
    4.7$ - 10.49$
  • Dividend Per Share
    --
  • Market cap
    747 M$
  • EPS
    -0.5
  • Beta
    2.936
  • Volume
    --

About

MNMD.US refers to the common stock of MindMed (Mind Medicine) Inc. traded on the NASDAQ stock exchange. MindMed is a biopharmaceutical company focused on discovering, developing, and deploying psychedelic-inspired medicines and therapies to address significant unmet needs in brain health. The ".US" suffix indicates that it's the company's stock traded on a United States exchange. Investors can buy and sell MNMD.US shares through brokerage accounts, and the stock's price fluctuates based on various market factors, company news, and investor sentiment surrounding the psychedelic medicine industry.

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

Market Sentiment: Overall investor mood towards psychedelic medicine and growth stocks influences buying/selling pressure.

Clinical Trial Results: Positive data from MindMed's clinical trials boosts investor confidence, while negative results can decrease it.

Regulatory Approvals: Anticipation and receipt of FDA approvals for MindMed's drugs are major catalysts for price increases.

Partnerships & Funding: Strategic collaborations and successful capital raises positively impact the stock price.

Competition: Advances by competitors in the psychedelic medicine space can dilute MindMed's potential market share.

Management Decisions: Key decisions made by MindMed's leadership team will affect the price of MNMD.US stocks.

People Also Watch

Latest news

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation

Ava Grace|--

US Intelligence: Iran Unwilling to Engage in Substantive Talks to End War

Sophia Claire|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--